Tag Archive for: immunoncology

Denmark’s complement system activator specialist Commit Biologics A/S has added  a €5.5m extension to its €16.5 seed financing. New investor Korys joined Novo Holdings and Bioqube Ventures.

Swiss cancer and auto-immunity specialist ImmunOs Therapeutics AG has closed a Series C financing round of US$11m led by existing investors Gimv, Pfizer Ventures, Mission BioCapital, BioMed Partners and supported by new investor Double Point Ventures.

Multiple factors determine whether tumor cells will be eliminated by the immune system or will escape detection.© wikimedia.com/By Frontiers in Oncology - http://www.frontiersin.org/files/Articles/51138/fonc-03-00197-HTML/image_m/fonc-03-00197-g001.jpg, CC BY 3.0, https://commons.wikimedia.org/w/index.php?curid=33585764

Bergen-based Cytovation ASA has raised US$8m in a Series A extension round to push its cancer compound CyPep-1 into Phase II clinical testing.

,

© Christaras A_wikimedia.com

An anti-TNF-antibody-cytokine fusion combo with chemotherapy turns inoperable brain tumours hot in mice. A Phase I trial sponsored by Philogen SpA is underway.

© Ono Pharmaceuticals Co Ltd

Edinburgh-based immuno-oncology expert Macomics Ltd has partnered with Ono Pharmaceutical to develop a macrophage-targeting antibody targetting cancer.

Lung cancer cells. © Evotec SE

Evotec SE and Janssen Biotech Inc have agreed to co-develop targeted immuno-oncological therapies.

© qimono/pixabay.com

Atara Biotherapeutics Inc. and Pierre Fabre SA announced the approval of Tabelecleucel, a therapy for a rare and potentially fatal malignancy.